Jeremy Chien

Jeremy Chien

University of California, Davis

H-index: 49

North America-United States

About Jeremy Chien

Jeremy Chien, With an exceptional h-index of 49 and a recent h-index of 31 (since 2020), a distinguished researcher at University of California, Davis, specializes in the field of Cancer Research, Cancer Genomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model

Cmpd10357 to treat B-cell acute lymphoblastic leukemia

Author Correction: Pan-cancer analysis of whole genomes

Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers

P640: Molecular findings of a placental mass in association with neonatal mosaic trisomy 21: Teratoma vs monozygotic acardiac amorphous twin

Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry

A Bioinformatics Analysis of Ovarian Cancer Data Using Machine Learning

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Jeremy Chien Information

University

Position

___

Citations(all)

13991

Citations(since 2020)

5546

Cited By

10746

hIndex(all)

49

hIndex(since 2020)

31

i10Index(all)

86

i10Index(since 2020)

66

Email

University Profile Page

University of California, Davis

Google Scholar

View Google Scholar Profile

Jeremy Chien Skills & Research Interests

Cancer Research

Cancer Genomics

Top articles of Jeremy Chien

Title

Journal

Author(s)

Publication Date

Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model

Pediatric Hematology and Oncology

Alex Q Lee

Hiroaki Konishi

Masami Ijiri

Yueju Li

Arun Panigrahi

...

2024/4/13

Cmpd10357 to treat B-cell acute lymphoblastic leukemia

Experimental hematology

Alex Q Lee

Hiroaki Konishi

Elizabeth Helmke

Masami Ijiri

Jan Michael A Lerot

...

2023/3/1

Author Correction: Pan-cancer analysis of whole genomes

Nature

2023/2/16

Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers

Gynecologic Oncology

Nancy T Nguyen

Alan Raetz

Dennis Montoya

Vincent Schilling

Caili Tong

...

2023/11/1

P640: Molecular findings of a placental mass in association with neonatal mosaic trisomy 21: Teratoma vs monozygotic acardiac amorphous twin

Genetics in Medicine Open

Madeleine Weiss

Zahabiya Chithiwala

Anthony Karnezis

Jeremy Chien

Herman Hedriana

...

2023/1/1

Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry

Frontiers in Immunology

Weijie Ma

Sixi Wei

Eddie C Tian

Bridget Mclaughlin

Maria Jaimes

...

2023/8/10

A Bioinformatics Analysis of Ovarian Cancer Data Using Machine Learning

Algorithms

Vincent Schilling

Peter Beyerlein

Jeremy Chien

2023/7/11

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Nature genetics

Isidro Cortés-Ciriano

Jake June-Koo Lee

Ruibin Xi

Dhawal Jain

Youngsook L Jung

...

2023/6

Exploiting ER Stress Pathway as a Target of Vulnerability in Ovarian Cancer

Jeremy Chien

CALIFORNIA UNIV DAVIS

2022/5/1

Targeting epigenetic modifiers of tumor plasticity and cancer stem cell behavior

Vigneshwari Easwar Kumar

Roshni Nambiar

Cristabelle De Souza

Audrey Nguyen

Jeremy Chien

...

2022/4/21

Synchronous basal cell carcinoma and squamous cell carcinoma of nasal vestibule with novel unique variants identified by whole-exome sequencing

in vivo

Ida Ghlichloo

Zhongbo Jin

Ruohao Fan

Caili Tong

Petr Starostik

...

2022/1/1

5 Targeting NF1/RAS pathway mutations in high-grade serous ovarian carcinoma (HGSOC) with a novel dual-mechanism ERK 1/2 inhibitor to improve chemotherapy sensitivity

Gynecologic Oncology Reports

Nicole Rubin

Rebecca Brooks

Gary Leiserowitz

Jeremy Chien

2022/12/1

Multiple components of protein homeostasis pathway can be targeted to produce drug synergies with VCP inhibitors in ovarian cancer

Cancers

Prabhakar Bastola

Gary S Leiserowitz

Jeremy Chien

2022/6/15

Ovarian serous carcinoma with a novel HSP90AB1 mutation in a patient with synchronous primary fallopian tube serous carcinoma

Anticancer Research

Jinping Lai

Caili Tong

Jeremy R Chien

2021/9/1

Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer

JNCI: Journal of the National Cancer Institute

Cristabelle De Souza

Jill Madden

Devin C Koestler

Dennis Minn

Dennis J Montoya

...

2021/9/1

Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy

Journal of the American Society of Nephrology

Laith Farah Al-Rabadi

Tiffany Caza

Claire Trivin-Avillach

Aylin R Rodan

Nicole Andeen

...

2021/7/1

Quinacrine has preferential anticancer effects on mesothelioma cells with inactivating NF2 mutations

Frontiers in Pharmacology

Derek B Oien

Sayantani Sarkar Bhattacharya

Jeremy Chien

Julian Molina

Viji Shridhar

2021/9/21

Quinacrine induces nucleolar stress in treatment-refractory ovarian cancer cell lines

Cancers

Derek B Oien

Upasana Ray

Christopher L Pathoulas

Ling Jin

Prabhu Thirusangu

...

2021/9/16

MutEx: a multifaceted gateway for exploring integrative pan-cancer genomic data

Briefings in bioinformatics

Jie Ping

Olufunmilola Oyebamiji

Hui Yu

Scott Ness

Jeremy Chien

...

2020/7

Emerging Drug Therapies for Mesothelioma

Derek B Oien

Jeremy Chien

Julian Molina

Viji Shridhar

2020/6/15

See List of Professors in Jeremy Chien University(University of California, Davis)